DÄ internationalArchive19/2008Congenital Heart Disease in Pregnancy

Review article

Congenital Heart Disease in Pregnancy

Dtsch Arztebl Int 2008; 105(19): 347-54. DOI: 10.3238/arztebl.2008.0347

Uebing, A; Gatzoulis, M A; Kaisenberg, C v; Kramer, H; Strauss, A

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Universitätsklinikum Schleswig-Holstein, Klinik für Kinderkardiologie, Campus Kiel: Dr. med. Uebing, Prof. Dr. med. Kramer; Adult Congenital Heart Disease Unit, Royal Brompton Hospital, Sydney Street, London SW 3 6NP, Großbritannien: Prof. Dr. med. Gatzoulis; Universitätsklinik Schleswig-Holstein, Klinik für Gynäkologie und Geburtshilfe, Campus Kiel: PD Dr. med. von Kaisenberg, Prof. Dr. med. Strauss
1. Nieminen HP, Jokinen EV, Sairanen HI: Late results of pediatric cardiac surgery in Finland: a population-based study with 96% follow-up. Circulation 2001;104: 570–5.
2. Thorne S, Deanfield J: Long-term outlook in treated congenital heart disease. Arch Dis Child 1996; 75: 6–8.
3. Kaemmerer H, Hess J: Adult patients with congenital heart abnormalities: present and future. Dtsch Med Wochenschr 2005; 130: 97–101.
4. Lewis G, Drife JO: Why mothers die 2000–2002 – the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press 2004.
5. Task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761–81.
6. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA: Pregnancy and congenital heart disease. BMJ 2006; 332: 401–6.
7. Siu SC, Sermer M, Colman JM et al.: Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104: 515–21.
8. Siu SC, Sermer M, Harrison DA et al.: Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96: 2789–94.
9. Drenthen W, Pieper PG, Roos-Hesselink JW et al.: Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49: 2303–11.
10. Siu SC, Colman JM, Sorensen S et al.: Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002; 105: 2179–84.
11. Nora JJ: From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994; 23:1468–71.
12. Steer PJ, Gatzoulis MA, Baker P: Consensus views arising from the 51st study group: heart disease and pregnancy. In: Steer PJ, Gatzoulis MA, Baker P, (eds.): heart disease and pregnancy. London: Royal College of Obstetricians and Gynaecologists Press 2006; 327–32.
13. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH: Using fetal nuchal translucency to screen for major congenital cardiac defects at 10 to 14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81–5.
14. Hess J, Bauer U, de Haan F et al.: Empfehlungen für Erwachsenen- und Kinderkardiologen zum Erwerb der Zusatz-Qualifikation "Erwachsene mit angeborenen Herzfehlern" (EMAH). Clin Res Cardiol 2007; 2(Suppl 1): 19–26.
15. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004; 104: 647–51.
16. Leyendecker JR, Gorengaut V, Brown JJ: MR-imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics 2004; 24: 1301–16.
17. Schaefer C, Weber-Schöndorfer C: Medikamentöse Therapie in der Schwangerschaft. Dtsch Arztebl 2005; 102(37): A 2480–9.
18. Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL: Thrombus formation after the fontan operation. Ann Thorac Surg 2001; 71: 1990–4.
19. Bates SM, Greer IA, Hirsh J, Ginsberg JS: Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl): 627–44.
20. Immer FF, Bansi AG, Immer-Bansi AS et al.: Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 2003; 76: 309–14.
21. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ: Pregnancy outcomes in women with congenital heart disease. Circulation 2006; 113: 517–24.
22. Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000; 160: 191–6.
23. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M: Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 33: 1637–41.
24. Oran B, Lee-Parritz A, Ansell J: Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004; 92: 747–51.
25. Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J: Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve-replacement: a metaanalysis. Am Heart J 1995; 130: 547–52.
e1. Warnes CA: The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46: 1–8.
e2. Welsch H, Krone HA, Wisser J: Maternal mortality in Bavaria between 1983 and 2000. Am J Obstet Gynecol 2004; 191: 304–8.
e3. Kafka H, Johnson MR, Gatzoulis MA: The team approach to pregnancy and congenital heart disease. Cardiol Clin 2006; 24: 587–605.
e4. Steer PJ: Pregnancy and contraception. In: Gatzoulis MA, Swan L, Therrien J, Pantley GA, (eds.): Adult congenital heart disease: A practical guide. Oxford: BMJ Publishing Group, Blackwell Publishing Ltd 2005; 16–35.
e5. von Obernitz N, Strauss A: Fetal echocardiography – see with new eyes. Geburtsh Frauenheilk 2001; 61: 364–74.
e6. Bassett AS, Chow EW, Husted J et al.: Clinical features of 78 adults with 22q11-deletion-syndrome. Am J Med Genet A 2005; 138: 307–13.
e7. De Wilde JP, Rivers AW, Price DL: A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol 2005; 87: 335–53.
e8. Qasqas SA, McPherson C, Frishman WH, Elkayam U: Cardiovascular pharmaco-therapeutic considerations during pregnancy and lactation. Cardiol Rev 2004; 12: 201–21, 240–61.
e9. Siu SC, Colman JM: Heart disease and pregnancy. Heart 2001; 85: 710–5.
e10. James PR: Drugs in pregnancy. Cardiovascular disease. Best Pract Res Clin Obstet Gynaecol 2001; 15: 903–11.
e11. Elkayam U: Pregnancy through a prosthetic heart valve. J Am Coll Cardiol 1999; 33: 1642–5.
e12. Warnes C: Prosthetic heart valves. In: Steer PJ, Gatzoulis MA, Baker P (eds.): Heart disease and pregnancy. London: Royal College of Obstetrician and Gynaecologists Press 2006; 157–68.
e13. Lupton M, Oteng-Ntim E, Ayida G, Steer PJ: Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 2002; 14: 137–43.
e14. Monnery L, Nanson J, Charlton G: Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001; 87: 295–8.
e15. Abbas AE, Lester SJ, Connolly H: Pregnancy and the cardiovascular system. Int J Cardiol 2005; 98: 179–89.
e16. Schaefer C, Hannemann D, Meister R et al.: Vitamin-K-antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006; 95: 949–57.
e17. Elkayam U, Singh H, Irani A, Akhter MW: Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004; 9: 107–15.
e18. Imperiale TF, Petrulis AS: A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. Jama 1991; 266: 260–4.
e19. Klein LL, Galan HL: Cardiac disease in pregnancy. Obstet Gynecol Clin North Am 2004; 31: 429–59.
e20. Kobrynski LJ, Sullivan, KE: Velocardiofacial syndrome; DiGeorge syndrome: the chromosome 22q11 – two deletion syndromes. Lancet 2007; 370: 1443–52.